A carregar...

Retrospective Review of Combined Sirolimus and Simvastatin Therapy in Lymphangioleiomyomatosis

BACKGROUND: Combined simvastatin and sirolimus therapy reduces tuberous sclerosis complex 2-null lesions and alveolar destruction in a mouse model of lymphangioleiomyomatosis (LAM), suggesting that therapy with both drugs may benefit patients with LAM. METHODS: To determine whether simvastatin chang...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chest
Main Authors: Taveira-DaSilva, Angelo M., Jones, Amanda M., Julien-Williams, Patricia A., Stylianou, Mario, Moss, Joel
Formato: Artigo
Idioma:Inglês
Publicado em: American College of Chest Physicians 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4285076/
https://ncbi.nlm.nih.gov/pubmed/25167325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.14-0758
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!